Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

X

Researchers Identify Multi-Action Drug Candidate For Type 2 Diabetes And Bone Disease

Posted on: in News | Life Science News | Pharma News
By:

Related Vitals

Lilly and Resilience Invest $750M to Expand Medicine Production in Ohio
Lilly Resilience Ohio manufacturing investment
Pharmaville: Powering Life Sciences Location Strategy and FDI

Takeda to Invest Up to $30 Million in Indonesia Plasma Donation Pilot
Takeda Indonesia Plasma Pilot
Pharmaville: Powering Life Sciences Location Strategy and FDI

AdvanCell Raises $315M to Expand Radiopharmaceutical Manufacturing
The $315M will support late-stage development of AdvanCell’s lead prostate cancer program and a planned 128,000-square-foot manufacturing site in Massachusetts. Photo courtesy of AdvanCell.
News

What to Expect at Bisnow’s International Life Sciences & Biotech Conference 2026
News

FDA Proposes Drug Manufacturing Registration Rule
FDA drug manufacturing registration rule
News

Related Webinars

September 23, 2026

Improve Alzheimer’s Trial Readiness Through Patient and Caregiver Support
Hero - Desktop
September 22, 2026

Reduce Patient Burden in Clinical Trials Through Patient-Centricity
Hero - Desktop
September 09, 2026

Running Paediatric Gene Therapy Studies: Operations and Oversight in Practice
Hero - Desktop
September 22, 2026

Modernizing Centrifugation for Cell Separation, Washing and Recovery
Hero - Desktop
September 17, 2026

Planning for Accelerated Approval: Timing is Everything
Hero - Desktop